norditropin nordiflex 10 mg/1,5 ml
novo nordisk a/s - danemarca - somatropinum - sol. inj. in stilou injector preumplut - 10mg/1,5ml - hormoni ai lobului hipofizar anterior hormon somatotrop si agonisti ai acestuia
sogroya
novo nordisk a/s - somapacitan - creştere - hormoni hipofizari și hipotalamici și analogi - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).
oflo 2 mg/ml soluţie perfuzabilă
unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd.) - metoclopramidum - soluţie perfuzabilă - 2 mg/ml
metrogyl 10 mg/g gel vaginal
unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd.) - metronidazolum - gel vaginal - 10 mg/g
ificipro 2 mg/ml soluţie perfuzabilă
unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd.) - ciprofloxacinum - soluţie perfuzabilă - 2 mg/ml
lumykras
amgen europe bv - sotorasib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
lenalidomida alvogen 10 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare
lenalidomida alvogen 15 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare
lenalidomida alvogen 2,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 2,5mg - imunosupresoare alte imunosupresoare
lenalidomida alvogen 20 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare